We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.8%
AUM
$40.1B
AUM Growth
+$8.37B
(+26%)
Cap. Flow
+$13B
Cap. Flow
% of AUM
32.41%
Top 10 Holdings %
Top 10 Hldgs %
27.27%
Holding
5,081
New
1,977
Increased
1,066
Reduced
622
Closed
1,387
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$621M |
| 2 |
SNDK
Sandisk
SNDK
|
+$467M |
| 3 |
AbbVie
ABBV
|
+$205M |
| 4 |
Valero Energy
VLO
|
+$150M |
| 5 |
SoFi Technologies
SOFI
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$599M |
| 2 |
NVIDIA
NVDA
|
+$468M |
| 3 |
Applied Materials
AMAT
|
+$306M |
| 4 |
Apple
AAPL
|
+$280M |
| 5 |
Micron Technology
MU
|
+$260M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.83% |
| 2 | Financials | 6.27% |
| 3 | Industrials | 4.73% |
| 4 | Healthcare | 4.21% |
| 5 | Energy | 4.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Enel Chile
ENIC
$6.05B
| $74K | ﹤0.01% |
+19,029
| New | +$79.2K |
|
3402
Milestone Pharmaceuticals
MIST
$141M
| $74K | ﹤0.01% |
+62,256
| New | +$109K |
|
3403
Neuraxis
NRXS
$83.5M
| $74K | ﹤0.01% |
+10,010
| New | +$54.8K |
|
3404
Pangaea Logistics
PANL
$488M
| $74K | ﹤0.01% |
+10,573
| New | +$83.3K |
|
|
RZLV
3405
PUT
Rezolve AI
RZLV
$917M
| $74K | ﹤0.01% |
+29,000
| New | +$81.8K |
|
3406
Biomea Fusion
BMEA
$91.1M
| $73K | ﹤0.01% |
+47,852
| New | +$62.9K |
|
3407
CALL
TMC The Metals Company
TMC
$1.64B
| $73K | ﹤0.01% |
15,800
-25,500
| -62% | -$164K |
|
|
INFQ.WS
3408
Infleqtion Inc Warrants
INFQ.WS
| $71K | ﹤0.01% |
+16,134
| New | +$85.9K |
|
|
IMA
3409
ImageneBio Inc
IMA
$63.2M
| $69K | ﹤0.01% |
+13,909
| New | +$90.3K |
|
|
VIVO
3410
VivoPower PLC
VIVO
$120M
| $69K | ﹤0.01% |
+30,069
| New | +$67K |
|
|
ZH
3411
Zhihu
ZH
$279M
| $68K | ﹤0.01% |
+24,144
| New | +$81.5K |
|
|
NIXX
3412
Nixxy Inc
NIXX
$19.8M
| $68K | ﹤0.01% |
+64,458
| New | +$48.2K |
|
3413
ChargePoint
CHPT
$140M
| $67K | ﹤0.01% |
+13,921
| New | +$84.8K |
|
|
TSYY
3414
GraniteShares YieldBOOST TSLA ETF
TSYY
$63.3M
| $67K | ﹤0.01% |
2,441
-645
| -21% | -$22.6K |
|
|
KLRS
3415
Kalaris Therapeutics
KLRS
$85.2M
| $67K | ﹤0.01% |
+11,617
| New | +$103K |
|
3416
Five Point Holdings
FPH
$385M
| $66K | ﹤0.01% |
+13,840
| New | +$74.3K |
|
|
NCTY
3417
The9 Ltd
NCTY
$69.3M
| $65K | ﹤0.01% |
+12,025
| New | +$73K |
|
3418
BlackRock Enhanced International Dividend Trust
BGY
$515M
| $64K | ﹤0.01% |
+11,969
| New | +$70.2K |
|
3419
Standard BioTools
LAB
$303M
| $64K | ﹤0.01% |
70,522
-23,260
| -25% | -$28.2K |
|
3420
AdvisorShares MSOS 2X Daily ETF
MSOX
$49.4M
| $64K | ﹤0.01% |
+30,158
| New | +$96.7K |
|
|
BCHT
3421
Birchtech Corp
BCHT
$37.6M
| $64K | ﹤0.01% |
+33,855
| New | +$73.9K |
|
3422
Greystone Housing Impact Investors LP
GHI
$125M
| $63K | ﹤0.01% |
12,981
-1,765
| -12% | -$12.8K |
|
|
SLN
3423
Silence Therapeutics
SLN
$570M
| $63K | ﹤0.01% |
+11,994
| New | +$66K |
|
3424
CALL
C4 Therapeutics
CCCC
$397M
| $62K | ﹤0.01% |
+23,700
| New | +$55.8K |
|
|
AUNA
3425
Auna
AUNA
$378M
| $62K | ﹤0.01% |
+11,411
| New | +$58.3K |
|
Similar funds
HRT Financial's Q1 2026 Portfolio in Review
As of Q1 2026, HRT Financial held 5,081 positions worth $40.1B, up 26% from $31.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
HRT Financial deployed $13B of net new capital in Q1 2026, opening 1,977 new positions and adding to 1,066 existing holdings. Its largest new stake was AbbVie: 926,410 shares worth $201M.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 15% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Broadcom, an estimated $599M trimmed.
- HRT Financial's largest Q1 2026 buy was AbbVie: 926,410 shares worth $201M.
- HRT Financial added most to Invesco QQQ Trust in Q1 2026, an estimated $621M increase.
- HRT Financial's biggest Q1 2026 reduction was Broadcom, cutting an estimated $599M.
- HRT Financial fully exited NVIDIA in Q1 2026, selling an estimated $468M.
- HRT Financial's ten largest holdings make up 27% of its $40.1B portfolio in Q1 2026.
- HRT Financial opened 1,977 new positions and closed 1,387 in Q1 2026.
- HRT Financial's portfolio value rose 26% quarter-over-quarter to $40.1B.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.